TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
Clinical trial NCT03529448 · COMPLETED
Trial details
- NCT number
- NCT03529448
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2025-11-13
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.